TRK-820, a selective kappa opioid receptor agonist, could effectively ameliorate L-DOPA-induced dyskinesia symptoms in a rat model of Parkinson's disease

Autor: Ikeda, Ken, Yoshikawa, Satoru, Kurokawa, Takahiro, Yuzawa, Natsumi, Nakao, Kaoru, Mochizuki, Hidenori
Zdroj: In European Journal of Pharmacology 2009 620(1):42-48
Databáze: ScienceDirect